520 related articles for article (PubMed ID: 16116224)
61.
Bomfim CCB; Fisher L; Amaral EP; Mittereder L; McCann K; Correa AAS; Namasivayam S; Swamydas M; Moayeri M; Weiss JM; Chari R; McVicar DW; Costa DL; D'Império Lima MR; Sher A
Front Cell Infect Microbiol; 2022; 12():862582. PubMed ID: 35586249
[TBL] [Abstract][Full Text] [Related]
62. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
[TBL] [Abstract][Full Text] [Related]
63. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
64. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.
Fernandez S; Jose P; Avdiushko MG; Kaplan AM; Cohen DA
J Immunol; 2004 Feb; 172(4):2613-20. PubMed ID: 14764735
[TBL] [Abstract][Full Text] [Related]
65. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
[TBL] [Abstract][Full Text] [Related]
66. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
67. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
68. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.
Mancuso G; Midiri A; Beninati C; Biondo C; Galbo R; Akira S; Henneke P; Golenbock D; Teti G
J Immunol; 2004 May; 172(10):6324-9. PubMed ID: 15128822
[TBL] [Abstract][Full Text] [Related]
69. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.
Mun HS; Aosai F; Norose K; Chen M; Piao LX; Takeuchi O; Akira S; Ishikura H; Yano A
Int Immunol; 2003 Sep; 15(9):1081-7. PubMed ID: 12917260
[TBL] [Abstract][Full Text] [Related]
70. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
[TBL] [Abstract][Full Text] [Related]
71. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S
Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868
[TBL] [Abstract][Full Text] [Related]
72. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
73. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages.
Rhee SH; Jones BW; Toshchakov V; Vogel SN; Fenton MJ
J Biol Chem; 2003 Jun; 278(25):22506-12. PubMed ID: 12686553
[TBL] [Abstract][Full Text] [Related]
74. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
75. Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles.
Muralidharan S; Lim A; Catalano D; Mandrekar P
J Immunol; 2018 Apr; 200(7):2291-2303. PubMed ID: 29445009
[TBL] [Abstract][Full Text] [Related]
76. Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ.
Stokes JA; Corr M; Yaksh TL
Pain; 2013 May; 154(5):733-742. PubMed ID: 23489833
[TBL] [Abstract][Full Text] [Related]
77. Type I interferon induced by TLR2-TLR4-MyD88-TRIF-IRF3 controls Mycobacterium abscessus subsp. abscessus persistence in murine macrophages via nitric oxide.
Ruangkiattikul N; Rys D; Abdissa K; Rohde M; Semmler T; Tegtmeyer PK; Kalinke U; Schwarz C; Lewin A; Goethe R
Int J Med Microbiol; 2019 Jul; 309(5):307-318. PubMed ID: 31178418
[TBL] [Abstract][Full Text] [Related]
78. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.
Johnson AC; Heinzel FP; Diaconu E; Sun Y; Hise AG; Golenbock D; Lass JH; Pearlman E
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):589-95. PubMed ID: 15671286
[TBL] [Abstract][Full Text] [Related]
79. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages.
Galdiero M; Galdiero M; Finamore E; Rossano F; Gambuzza M; Catania MR; Teti G; Midiri A; Mancuso G
Infect Immun; 2004 Feb; 72(2):1204-9. PubMed ID: 14742577
[TBL] [Abstract][Full Text] [Related]
80. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
